Skip to content
HowShorted

Fulgent Genetics, Inc. short interest in 2021

In 2021, Fulgent Genetics, Inc.'s disclosed short interest ran from 17.06% of shares outstanding on 15 Jan 2021 to 6.18% on 31 Dec 2021, a change of -10.88 percentage points. The year's high was 21.14% on 15 Apr 2021 and its low 6.18% on 31 Dec 2021, averaging 14.55% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.03 days on 28 May 2021. Full history: Fulgent Genetics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Fulgent Genetics, Inc. in 2021

2021 in figures

Start of year
17.06% (15 Jan 2021)
End of year
6.18% (31 Dec 2021)
Change
-10.88 pp
High
21.14% (15 Apr 2021)
Low
6.18% (31 Dec 2021)
Average
14.55%
Highest days to cover
12.03 (28 May 2021)
SEC filings marked
8

Every report in 2021

Fulgent Genetics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202117.06%1.72
29 Jan 202117.20%2.48
12 Feb 202111.92%1.29
26 Feb 202116.29%2.45
15 Mar 202115.88%2.05results (8-K), 10-K filed
31 Mar 202119.99%3.45
15 Apr 202121.14%5.82
30 Apr 202120.87%7.80
14 May 202120.33%4.76results (8-K), 10-Q filed
28 May 202119.63%12.03
15 Jun 202119.88%7.09
30 Jun 202119.39%6.41
15 Jul 202118.16%8.08
30 Jul 202115.54%6.37
13 Aug 202113.03%3.97results (8-K), 10-Q filed
31 Aug 202111.70%6.88
15 Sep 202111.21%6.48
30 Sep 202110.07%6.95
15 Oct 202110.05%6.15
29 Oct 20219.38%10.64
15 Nov 20218.90%5.3210-Q filed, results (8-K)
30 Nov 20218.45%4.67
15 Dec 20216.98%4.49
31 Dec 20216.18%3.68

See also: Fulgent Genetics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.